{"id":"placebo-for-pentoxifylline","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebos are inert substances used as controls in clinical trials to establish the efficacy of active drugs through comparison. Any observed effects in placebo groups are attributed to the placebo effect—psychological and physiological responses to the expectation of treatment rather than to a drug mechanism. In this case, the placebo is being used as a control arm in trials evaluating Pentoxifylline.","oneSentence":"A placebo contains no active pharmaceutical ingredient and produces no pharmacological effect.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:36:09.815Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Control arm in clinical trials for Pentoxifylline efficacy evaluation"}]},"trialDetails":[{"nctId":"NCT06634056","phase":"PHASE2","title":"Pneumonitis Prevention Protocol Using Pentoxifylline and α-tocopherol In Stage III Non-Small Cell Lung Cancer Patients Undergoing Chemoradiation","status":"NOT_YET_RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2026-05-30","conditions":"Non-Small Cell Lung Cancer, Radiation Induced Lung Injury (RILI)","enrollment":150},{"nctId":"NCT07349472","phase":"PHASE2","title":"Pentoxifylline in Patients With Ulcerative Colitis","status":"NOT_YET_RECRUITING","sponsor":"Ihab Elsayed Hassan","startDate":"2026-01-20","conditions":"Inflammatory Bowel Diseases","enrollment":60},{"nctId":"NCT03625648","phase":"PHASE4","title":"Pentoxifylline in Diabetic Kidney Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2019-11-18","conditions":"Diabetic Kidney Disease","enrollment":2376},{"nctId":"NCT06055257","phase":"PHASE3","title":"Combination Therapy: Hyperbaric Oxygen and PENTOCLO for Treatment of Osteoradionecrosis of the Mandible","status":"RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2025-01-16","conditions":"Osteoradionecrosis, Osteoradionecrosis of Jaw, Osteoradionecrosis of the Mandible","enrollment":24},{"nctId":"NCT07088328","phase":"NA","title":"Nephroprotection Following Perinatal Asphyxia: Randomized Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"Alexandria University","startDate":"2025-07-30","conditions":"Hypoxic-Ischemic Encephalopathy, Neonatal Encephalopathy, Pentoxifylline Adverse Reaction","enrollment":30},{"nctId":"NCT07017114","phase":"PHASE1","title":"Pentoxifylline PKB171 Gel in Healthy Females Volunteers","status":"COMPLETED","sponsor":"Prokrea BCN, S.L.","startDate":"2016-01-27","conditions":"Safety, Pharmacokinetics, Maximum Tolerated Dose","enrollment":30},{"nctId":"NCT06986031","phase":"PHASE2","title":"PKB171 Against Placebo in Couples With Asthenozoospermia Who Wish to Conceive","status":"TERMINATED","sponsor":"Prokrea BCN, S.L.","startDate":"2017-05-08","conditions":"Infertility, Male","enrollment":60},{"nctId":"NCT02592863","phase":"NA","title":"Trental for the Treatment of Vertigo/Dizziness/Imbalance","status":"TERMINATED","sponsor":"University of Missouri-Columbia","startDate":"2015-01","conditions":"Dizziness, Vertigo","enrollment":26},{"nctId":"NCT03040778","phase":"PHASE3","title":"Pentoxifylline and Tocopherol (PENTO) in the Treatment of Medication-related Osteonecrosis of the Jaw (MRONJ)","status":"ENROLLING_BY_INVITATION","sponsor":"University of Washington","startDate":"2018-04-01","conditions":"Medication-related Osteonecrosis of the Jaw, Bisphosphonate-related Osteonecrosis of the Jaw, Avascular Necrosis","enrollment":100},{"nctId":"NCT05189535","phase":"PHASE2, PHASE3","title":"\"Prevention of Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer Patients\"","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2021-10-03","conditions":"Breast Cancer Female, Peripheral Neuropathy","enrollment":66},{"nctId":"NCT04186559","phase":"PHASE2","title":"Topical Pentoxifylline Gel on Behcet's Disease Genital Ulcers","status":"UNKNOWN","sponsor":"Silk Road Therapies, Inc.","startDate":"2024-02","conditions":"Behcet Syndrome, Behcet Disease","enrollment":60},{"nctId":"NCT04094207","phase":"PHASE1, PHASE2","title":"Pentoxifylline as an Adjunctive in Treatment of Negative Symptoms in Chronic Schizophrenia","status":"COMPLETED","sponsor":"Sadat City University","startDate":"2019-01-01","conditions":"Schizophrenia","enrollment":80},{"nctId":"NCT05324735","phase":"PHASE1, PHASE2","title":"Pentoxifylline for Treatment of Resistant Major Depression","status":"COMPLETED","sponsor":"Hawler Medical University","startDate":"2021-12-15","conditions":"Resistant Major Depression","enrollment":60},{"nctId":"NCT05271084","phase":"PHASE1, PHASE2","title":"Pentoxifylline as an Adjunct to Citalopram in Adult Patients With Major Depressive Disorder","status":"COMPLETED","sponsor":"Hawler Medical University","startDate":"2021-11-10","conditions":"Major Depressive Disorder","enrollment":100},{"nctId":"NCT04367935","phase":"PHASE2, PHASE3","title":"Effect of Pentoxifylline on Endothelial Dysfunction in Patients With Acute Coronary Syndrome","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2021-01-01","conditions":"Acute Coronary Syndrome","enrollment":43},{"nctId":"NCT01337349","phase":"NA","title":"Effects of Pentoxiphylline on Left Ventricular (LV) Systolic Function Indices and Circulating Biomarkers in Patients With Chronic Congestive Heart Failure (CHF)","status":"WITHDRAWN","sponsor":"Henry Ford Health System","startDate":"2010-07","conditions":"Congestive Heart Failure","enrollment":""},{"nctId":"NCT05073640","phase":"PHASE1, PHASE2","title":"Pentoxifylline Add-on Therapy for Schizophrenia","status":"UNKNOWN","sponsor":"Mazra Mental Health Center","startDate":"2019-04-20","conditions":"Schizophrenia","enrollment":90},{"nctId":"NCT03859570","phase":"PHASE4","title":"Pentoxifylline in Lupus Nephritis","status":"WITHDRAWN","sponsor":"MetroHealth Medical Center","startDate":"2020-09-01","conditions":"Lupus Nephritis","enrollment":""},{"nctId":"NCT03554447","phase":"NA","title":"Role of Pentoxifylline as an Adjuvant Therapy for Adult Patients With Major Depressive Disorder","status":"COMPLETED","sponsor":"Mahmoud Samy Abdallah","startDate":"2015-04-20","conditions":"Major Depressive Disorder","enrollment":80},{"nctId":"NCT02230800","phase":"PHASE2","title":"PPALM-Palm Oil and Pentoxifylline Against Late Morbidity","status":"COMPLETED","sponsor":"Royal Marsden NHS Foundation Trust","startDate":"2014-11-25","conditions":"Long-term Adverse Effects of Radiotherapy for Pelvic Cancer","enrollment":62},{"nctId":"NCT02123576","phase":"NA","title":"Treatment of Type I Hepatorenal Syndrome (HRS) With Pentoxyfylline","status":"TERMINATED","sponsor":"Patrick Northup, MD","startDate":"2014-04","conditions":"Hepatorenal Syndrome","enrollment":12},{"nctId":"NCT02487225","phase":"PHASE3","title":"Pentoxifylline Treatment in Acute Pancreatitis (AP)","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2015-05","conditions":"Acute Pancreatitis (AP), Gallstone Pancreatitis, Alcoholic Pancreatitis","enrollment":83},{"nctId":"NCT00315679","phase":"NA","title":"A Trial of Pentoxifylline for the Treatment of Recurrent Aphthous Stomatitis","status":"COMPLETED","sponsor":"Manchester University NHS Foundation Trust","startDate":"1996-06","conditions":"Recurrent Aphthous Stomatitis","enrollment":30},{"nctId":"NCT02451774","phase":"PHASE2, PHASE3","title":"Pentoxifylline In Pediatric Acute Lymphoblastic Leukemia During Induction","status":"UNKNOWN","sponsor":"Ramón Óscar González-Ramella, Ph.D","startDate":"2015-01","conditions":"Acute Lymphoblastic Leukemia","enrollment":44},{"nctId":"NCT01291433","phase":"PHASE3","title":"Trial of Combined Pentoxifylline-tocopherol-clodronate vs Placebo in Radiation-induced Brachial Plexopathy","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2011-03","conditions":"Radiation Induced Brachial Plexopathy","enrollment":59},{"nctId":"NCT00770328","phase":"PHASE4","title":"The Effects of Pentoxifylline on PAI-1 in an Obese Population","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2003-05","conditions":"Obesity","enrollment":37},{"nctId":"NCT00796822","phase":"PHASE2","title":"Evaluating the Effectiveness of Pentoxifylline at Improving Blood Vessel Function in HIV-infected People Not Receiving Antiretroviral Medications","status":"COMPLETED","sponsor":"Indiana University","startDate":"2009-01","conditions":"HIV, Cardiovascular Diseases, Atherosclerosis","enrollment":26},{"nctId":"NCT02992678","phase":"EARLY_PHASE1","title":"Pentoxifylline for the Prevention of PEP","status":"UNKNOWN","sponsor":"Anhui Provincial Hospital","startDate":"2016-12","conditions":"Pancreatitis","enrollment":110},{"nctId":"NCT01377285","phase":"PHASE4","title":"Renoprotection by Pentoxifylline and Angiotensin Receptor Blocker in Chronic Kidney Disease (CKD)","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"2010-06","conditions":"Chronic Renal Failure","enrollment":350},{"nctId":"NCT01464242","phase":"PHASE2, PHASE3","title":"Add-on Study of Pentoxifylline in Cutaneous Leishmaniasis","status":"COMPLETED","sponsor":"Centro Internacional de Entrenamiento e Investigaciones Médicas","startDate":"2011-11","conditions":"Cutaneous Leishmaniasis","enrollment":75},{"nctId":"NCT02796469","phase":"","title":"Meta-Analysis of Drug Therapy in Patients With Severe Alcoholic Hepatitis","status":"COMPLETED","sponsor":"University Hospital, Lille","startDate":"2015-05","conditions":"Alcoholic Hepatitis, Alcoholic Liver Disease","enrollment":1974},{"nctId":"NCT01625845","phase":"PHASE2","title":"Anti-INFLammatory to Address Mood and Endothelial Dysfunction (INFLAMED)","status":"COMPLETED","sponsor":"Indiana University","startDate":"2012-06","conditions":"Major Depressive Disorder, Depression, Depressive Symptoms","enrollment":36},{"nctId":"NCT01144091","phase":"NA","title":"Renal Effect of Pentoxyphylline in High Risk Patients Undergoing Angiography","status":"WITHDRAWN","sponsor":"Meir Medical Center","startDate":"2012-12","conditions":"Contrast Induced Nephropathy, Diabetes Mellitus","enrollment":""},{"nctId":"NCT02163174","phase":"PHASE3","title":"Pentoxifylline and Late Onset Sepsis in Preterm Infants","status":"COMPLETED","sponsor":"Abd Elazeez Attala Shabaan","startDate":"2011-05","conditions":"Neonatal Late Onset Sepsis","enrollment":120},{"nctId":"NCT00205049","phase":"PHASE1","title":"Pentoxifylline for Acute Alcoholic Hepatitis (AAH)","status":"TERMINATED","sponsor":"University of Wisconsin, Madison","startDate":"2005-03","conditions":"Hepatitis, Alcoholic","enrollment":4},{"nctId":"NCT00864916","phase":"PHASE2","title":"Pentoxifylline and Combination Antiretroviral Therapy to Improve Blood Vessel Function in HIV-Infected People","status":"COMPLETED","sponsor":"Indiana University","startDate":"2009-03","conditions":"HIV, Vascular Diseases, Cardiovascular Diseases","enrollment":19},{"nctId":"NCT01676597","phase":"NA","title":"Efficacy of Pentoxifylline and Rifaximin Combination in Pentoxifylline Refractory Clinical and Subclinical Hepatopulmonary Syndrome","status":"UNKNOWN","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2012-09","conditions":"Hepatopulmonary Syndrome","enrollment":80},{"nctId":"NCT00022204","phase":"PHASE2","title":"Vitamin E and Pentoxifylline in Treating Women With Lymphedema After Radiation Therapy for Breast Cancer","status":"COMPLETED","sponsor":"Royal Marsden NHS Foundation Trust","startDate":"2000-01","conditions":"Breast Cancer, Lymphedema","enrollment":""},{"nctId":"NCT01214226","phase":"PHASE3","title":"Double-blind Randomized Controlled Trial in Severe Alcoholic Hepatitis","status":"COMPLETED","sponsor":"University Hospital, Lille","startDate":"2007-12","conditions":"Alcoholic Hepatitis, Alcoholic Liver Disease","enrollment":278},{"nctId":"NCT01006499","phase":"PHASE4","title":"Role of 'Pentoxifylline and or IgM Enriched Intravenous Immunoglobulin in the Treatment of Neonatal Sepsis'","status":"UNKNOWN","sponsor":"Zekai Tahir Burak Women's Health Research and Education Hospital","startDate":"2009-08","conditions":"Sepsis of the Newborn","enrollment":204},{"nctId":"NCT00632697","phase":"PHASE3","title":"Pentoxifylline and Endometriosis","status":"COMPLETED","sponsor":"Hospital Clinic of Barcelona","startDate":"2001-10","conditions":"Endometriosis-Associated Infertility","enrollment":104}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":480,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Placebo(non treatment)"],"phase":"marketed","status":"active","brandName":"Placebo (for Pentoxifylline)","genericName":"Placebo (for Pentoxifylline)","companyName":"National Taiwan University Hospital","companyId":"national-taiwan-university-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"A placebo contains no active pharmaceutical ingredient and produces no pharmacological effect. Used for Control arm in clinical trials for Pentoxifylline efficacy evaluation.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}